MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKDMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKDMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD

MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪438.20 M‬HKD
Fund flows (1Y)
‪−58.94 M‬HKD
Dividend yield (indicated)
Discount/Premium to NAV
2.5%
Shares outstanding
‪6.90 M‬
Expense ratio
0.68%

About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Inception date
Jul 25, 2019
Index tracked
Solactive China Biotech Index
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
Mirae Asset Global Investments (Hong Kong) Ltd.
ISIN
HK0000516697
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Cash
Stock breakdown by region
100%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to 2820 via country, focus, and more.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
2820 trades at 60.28 HKD today, its price has fallen −4.94% in the past 24 hours. Track more dynamics on 2820 price chart.
2820 net asset value is 62.86 today — it's risen 18.73% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
2820 assets under management is ‪438.20 M‬ HKD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
2820 price has risen by 15.95% over the last month, and its yearly performance shows a 37.25% increase. See more dynamics on 2820 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 18.73% over the last month, showed a 18.11% increase in three-month performance and has increased by 40.32% in a year.
2820 fund flows account for ‪−58.94 M‬ HKD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
2820 invests in stocks. See more details in our Analysis section.
2820 expense ratio is 0.68%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 2820 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 2820 technical analysis shows the buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 2820 shows the buy signal. See more of 2820 technicals for a more comprehensive analysis.
No, 2820 doesn't pay dividends to its holders.
2820 trades at a premium (2.45%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
2820 shares are issued by Mirae Asset Global Investments Co., Ltd.
2820 follows the Solactive China Biotech Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Jul 25, 2019.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.